Posts

Showing posts with the label Postpartum Depression (PPD) market outlook

Postpartum Depression (PPD) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034

Postpartum Depression (PPD)  Market Outlook Thelansis’s “Postpartum Depression (PPD)   Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2024 To 2034" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Postpartum Depression (PPD)   treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). Postpartum Depression (PPD)   Overview Postpartum depression (PPD) is a severe health issue affecting about 15% of the female population after giving birth. It often conveys significant adverse consequences to the offspring. The symptoms and risk factors are similar to those found in non-postpartum depression. The main difference resides in the fact that PPD is triggered by postpartum-specific factors, i...